Organisation paid for research Program year 2022 Source: CMS Open Payments

Aapri Asthma and Allergy Physicians of Rhode Island

Neither a doctor nor a teaching hospital

Research payments

$17,019

7 payments

Through program year 2022, Aapri Asthma and Allergy Physicians of Rhode Island is reported as receiving $17,019 in research payments, across 7 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2022	Research	$827	1
2021	Research	$13,500	3
2020	Research	$2,692	3

Breakdown

Who paid Research payments · program years 2020–2022

AstraZeneca Pharmaceuticals LP $17,019 7 payments

Studies the money was for Research payments · program years 2020–2022

A Multicentre Randomized Double Blind Placebo Controlled Parallel Group Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe Uncontrolled Asthma $13,034 2 payments
A Randomized Double-Blind Parallel Group Multi-Center 24-Week Study Comparing the Efficacy and Safety of Three Doses of PT001 to Placebo and Open-label Spiriva Respimat in Subjects With Persistent Asthma $2,225 2 payments
The CHRONICLE Study is a multi center non interventional prospective cohort study of adults with severe asthma who do not achieve control with high dose inhaled corticosteroid ICS therapy with additional controllers and or require systemic corticosteroid or monoclonal antibody therapy $933 2 payments
The CHRONICLE Study is a multi center,non interventional,prospective cohort study of adults with severe asthma who do not achieve control with high-dose ICS therapy with additional controllers and or require systemic corticosteroid or monoclonal antibod $827 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.